Top 10 Medical Stocks To Buy Right Now

Incyte (NASDAQ: EXEL) and Exelixis (NASDAQ:EXEL) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

Insider and Institutional Ownership

Get Incyte alerts:

91.5% of Incyte shares are held by institutional investors. Comparatively, 80.9% of Exelixis shares are held by institutional investors. 17.2% of Incyte shares are held by insiders. Comparatively, 4.8% of Exelixis shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Risk & Volatility

Incyte has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500. Comparatively, Exelixis has a beta of 1.96, suggesting that its share price is 96% more volatile than the S&P 500.

Top 10 Medical Stocks To Buy Right Now: KLA-Tencor Corporation(KLAC)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage loss in the S&P 500 ahead of the close was KLA-Tencor Corp. (NASDAQ: KLAC) which fell about 10% to $106.52. The stock’s 52-week range is $93.76 to $123.96. Volume was about 3.5 million compared to the daily average volume of 1.4 million.

  • [By Max Byerly]

    Canada Pension Plan Investment Board cut its stake in KLA-Tencor Corp (NASDAQ:KLAC) by 67.8% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 85,713 shares of the semiconductor company’s stock after selling 180,157 shares during the period. Canada Pension Plan Investment Board owned approximately 0.05% of KLA-Tencor worth $8,788,000 at the end of the most recent reporting period.

  • [By Jon C. Ogg]

    Investors are often concerned about the stock market in September, and the investment community is getting another look ahead at the lack of strength in the semiconductor capital equipment segment. Presenting at the Citi Global Technology Conference, KLA-Tencor Corp. (NASDAQ: KLAC) sent the whole industry lower on Thursday after tweaking its recovery expectations.

  • [By Timothy Green]

    Kulicke and Soffa Industries (NASDAQ:KLIC) is not a well-known company. The semiconductor packaging equipment specialist is valued at just $1.65 billion, and it recorded just $809 million of revenue last year. That’s a much smaller number than those posted by semiconductor equipment giants like Applied Materials (NASDAQ:AMAT), KLA-Tencor (NASDAQ:KLAC), and Lam Research (NASDAQ:LRCX).

Top 10 Medical Stocks To Buy Right Now: Estee Lauder Companies, Inc. (EL)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Estee Lauder Companies Inc. (NYSE: EL) was started as Outperform with a $170 price target (versus a $147.88 close) at Evercore ISI.

    Intuit Inc. (NASDAQ: INTU) was downgraded to Underweight from Equal Weight with a $160 price target (versus a $190.54 close) at First Analysis. Credit Suisse maintained its Outperform rating but raised its target price to $215 from $195.

  • [By Motley Fool Staff]

    The cast reaches for the mailbag in this segment from Industry Focus: Consumer Goods. Listener Joseph wants to know why Estée Lauder (NYSE:EL) and Ulta Beauty (NASDAQ:ULTA), both leading names in the skincare and cosmetics industry, have seen their stocks move in opposite directions over the past year.

  • [By Jeremy Bowman]

    Shares of Estee Lauder (NYSE:EL) were looking stunning today as the stock jumped after the cosmetics giant posted a blowout second-quarter earnings report and raised its full-year guidance.

  • [By Ethan Ryder]

    Estee Lauder Companies Inc (NYSE:EL) shares gapped down before the market opened on Monday . The stock had previously closed at $156.97, but opened at $152.93. Estee Lauder Companies shares last traded at $145.62, with a volume of 2849125 shares trading hands.

Top 10 Medical Stocks To Buy Right Now: LiqTech International, Inc.(LIQT)

Advisors’ Opinion:

  • [By Shane Hupp]

    LiqTech International Inc (NYSEAMERICAN:LIQT) saw a significant decline in short interest in the month of June. As of June 15th, there was short interest totalling 320,188 shares, a decline of 9.3% from the May 31st total of 352,974 shares. Currently, 0.6% of the company’s shares are short sold. Based on an average daily volume of 364,702 shares, the short-interest ratio is presently 0.9 days.

  • [By Money Morning Staff Reports]

    However, it’s unlikely Netlist repeats these returns anytime soon. After looking at last week’s top performing penny stocks, we’ll show you a penny stock on the verge of jumping over 230%…

    Penny Stock Current Share Price Last Week’s Gain
    Netlist Inc. (Nasdaq: NLST) $0.83 542.67%
    Mannkind Corp. (Nasdaq: MNKD) $1.80 79.09%
    Fred’s Inc. (Nasdaq: FRED) $2.49 73.68%
    Delcath Systems Inc. (OTCMKTS: DCTH) $3.70 72.63%
    Gemphire Therapeutics Inc. (Nasdaq: GEMP) $1.96 50.71%
    Bellerophon Therapeutics Inc. (Nasdaq: BLPH) $1.05 47.98%
    Cel-Sci Corp. (NYSE: CVM) $3.78 44.78%
    ParkerVision Inc. (OTCMKTS: PRKR) $0.60 29.42%
    Superior Drilling Products Inc. (NYSE: SDPI) $2.63 29.23%
    LiqTech International Inc. (NYSE: LIQT) $1.50 25.20%

    How to Profit off This $11.1 Billion Money Pool: By following a few simple steps, one IRS directive could help set you up to receive checks of up to $1,795 every single month thanks to a genius investment. Learn more…

  • [By Money Morning Staff Reports]

    But Blink and our other penny stocks to watch are unlikely to continue to lock in such spectacular gains in June. After looking at our 10 top penny stocks to watch this month, we’ll show you a small-cap stock with great profit potential in its future…

    Penny Stock Current Share Price Law Month’s Gain
     Blink Charging Co. (Nasdaq: BLNK) $7.07 439.85%
    Senes Tech Inc. (Nasdaq: SNES) $1.27 175.40%
    Vivis Inc. (Nasdaq: VVUS) $0.77 150.41%
    Adomani Inc. (Nasdaq: ADOM) $1.49 137.68%
    NF Energy Saving Co. (Nasdaq: NFEC) $2.34 134.88%
    Vaalco Energy Inc. (NYSE: EGY) $2.15 109.06%
    Heat Biologics Inc. (Nasdaq: HTBX) $2.35 99.12%
    ArQule Inc. (Nasdaq: ARQL) $4.88 90.74%
    LiqTech International Inc. (NYSE: LIQT) $0.66 85.60%
    Transenterix Inc. (NYSE: TRXC) $3.46 77.84%

    While last month’s gains are tremendous, they also illustrate the inherent dangers that come with investing in penny stocks.

  • [By Logan Wallace]

    LiqTech International Inc (NYSEAMERICAN:LIQT) shares rose 11.2% during mid-day trading on Wednesday . The company traded as high as $0.94 and last traded at $0.91. Approximately 1,268,573 shares were traded during mid-day trading, an increase of 253% from the average daily volume of 359,292 shares. The stock had previously closed at $0.82.

  • [By Lisa Levin] Gainers
    Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 40.62 percent to close at $4.50 on Tuesday after reporting 2017 year-end results.
    MEI Pharma, Inc. (NASDAQ: MEIP) gained 34.39 percent to close at $3.40.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) gained 32.74 percent to close at $1.50 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Pfenex Inc. (NYSE: PFNX) surged 31.15 percent to close at $8.00 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) rose 21.07 percent to close at $11.09. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Genprex, Inc. (NASDAQ: GNPX) rose 20.23 percent to close at $10.58.
    Turtle Beach Corporation (NASDAQ: HEAR) shares gained 17.62 percent to close at $17.82.
    Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 17.1 percent to close at $5.82.
    Phoenix New Media Limited (NYSE: FENG) shares jumped 16.23 percent to close at $4.87 following Q1 earnings.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 16.04 percent to close at $3.69.
    PPDAI Group Inc. (NASDAQ: PPDF) climbed 15.99 percent to close at $7.98 following Q1 results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.93 percent to close at $3.42.
    LiqTech International, Inc. (NASDAQ: LIQT) gained 15.59 percent to close at $0.5532 following Q1 results.
    Sophiris Bio, Inc. (NASDAQ: SPHS) gained 13.92 percent to close at $3.52 on Tuesday following Q1 results.
    Euroseas Ltd. (NASDAQ: ESEA) jumped 13.4 percent to close at $2.37.
    Iteris, Inc. (NASDAQ: ITI) shares surged 13.05 percent to close
  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
    Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
    Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
    Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
    Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
    LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
    ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
    Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    MYnd

Top 10 Medical Stocks To Buy Right Now: Ecolab Inc.(ECL)

Advisors’ Opinion:

  • [By Neha Chamaria]

    Using the above method, I believe the following five stocks are some of the best Dividend Aristocrats to consider today.

    Dividend Aristocrat Payout Ratio (Last 12 Months) 5-Year Dividend CAGR*  10-Year Dividend CAGR*
    Ecolab (NYSE:ECL) 30.2% 12.9% 12.3%
    W.W. Grainger (NYSE:GWW) 45.7% 10.6% 14.2%
    Cintas Corporation (NASDAQ:CTAS) 23.7% 19.8% 13.1%
    Roper Technologies (NYSE:ROP) 14.6% 20.4% 18.5%
    A. O. Smith (NYSE:AOS) 33.6% 25.5% (2.2%)

    *Compound annual growth rate. Data source: S&P Global Market Intelligence. Table by author.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Ecolab (ECL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Ecolab Inc. (NYSE:ECL) – Jefferies Financial Group dropped their Q4 2018 EPS estimates for Ecolab in a report released on Tuesday, July 31st. Jefferies Financial Group analyst L. Alexander now anticipates that the basic materials company will post earnings per share of $1.73 for the quarter, down from their prior forecast of $1.74.

  • [By Logan Wallace]

    Investors bought shares of Ecolab Inc. (NYSE:ECL) on weakness during trading on Tuesday. $37.89 million flowed into the stock on the tick-up and $13.41 million flowed out of the stock on the tick-down, for a money net flow of $24.48 million into the stock. Of all stocks tracked, Ecolab had the 33rd highest net in-flow for the day. Ecolab traded down ($0.18) for the day and closed at $157.22

  • [By Logan Wallace]

    Argus Investors Counsel Inc. bought a new position in Ecolab Inc. (NYSE:ECL) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 1,829 shares of the basic materials company’s stock, valued at approximately $257,000.

  • [By Max Byerly]

    In other news, Chairman Douglas M. Baker, Jr. sold 40,025 shares of the stock in a transaction on Wednesday, November 7th. The shares were sold at an average price of $160.20, for a total transaction of $6,412,005.00. Following the completion of the sale, the chairman now directly owns 558,017 shares in the company, valued at $89,394,323.40. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Leslie S. Biller sold 2,811 shares of the stock in a transaction on Friday, November 30th. The stock was sold at an average price of $160.40, for a total transaction of $450,884.40. Following the sale, the director now owns 57,842 shares of the company’s stock, valued at $9,277,856.80. The disclosure for this sale can be found here. Corporate insiders own 1.50% of the company’s stock.

    ILLEGAL ACTIVITY NOTICE: “Ecolab (ECL) Updates Q4 Earnings Guidance” was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this story on another website, it was stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this story can be read at www.tickerreport.com/banking-finance/4125845/ecolab-ecl-updates-q4-earnings-guidance.html.

    About Ecolab

Top 10 Medical Stocks To Buy Right Now: Watts Water Technologies, Inc.(WTS)

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Watts Water Technologies Inc  (NYSE:WTS)Q4 2018 Earnings Conference CallFeb. 08, 2019, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Watts Water Technologies (WTS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Watts Water Technologies (WTS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    BNP Paribas Arbitrage SA lessened its stake in Watts Water Technologies Inc (NYSE:WTS) by 40.4% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 14,698 shares of the technology company’s stock after selling 9,975 shares during the quarter. BNP Paribas Arbitrage SA’s holdings in Watts Water Technologies were worth $1,142,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Northern Trust Corp lifted its stake in shares of Watts Water Technologies (NYSE:WTS) by 0.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 952,176 shares of the technology company’s stock after buying an additional 3,219 shares during the period. Northern Trust Corp owned approximately 2.79% of Watts Water Technologies worth $73,984,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    A number of institutional investors and hedge funds have recently made changes to their positions in WTS. SeaCrest Wealth Management LLC acquired a new position in Watts Water Technologies during the fourth quarter worth about $112,000. Xact Kapitalforvaltning AB acquired a new position in shares of Watts Water Technologies in the fourth quarter valued at approximately $224,000. Sawgrass Asset Management LLC acquired a new position in shares of Watts Water Technologies in the fourth quarter valued at approximately $270,000. Koch Industries Inc. raised its position in shares of Watts Water Technologies by 22.0% in the fourth quarter. Koch Industries Inc. now owns 3,821 shares of the technology company’s stock valued at $290,000 after buying an additional 690 shares during the last quarter. Finally, Quadrature Capital Ltd acquired a new position in shares of Watts Water Technologies in the fourth quarter valued at approximately $330,000. Institutional investors own 77.22% of the company’s stock.

    ILLEGAL ACTIVITY NOTICE: “Watts Water Technologies (WTS) Expected to Post Quarterly Sales of $362.52 Million” was originally posted by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark law. The legal version of this piece of content can be accessed at www.tickerreport.com/banking-finance/3380368/watts-water-technologies-wts-expected-to-post-quarterly-sales-of-362-52-million.html.

    Watts Water Technologies Company Profile

Top 10 Medical Stocks To Buy Right Now: PDF Solutions Inc.(PDFS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on PDF Solutions (PDFS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Russell Investments Group Ltd. lowered its stake in PDF Solutions, Inc. (NASDAQ:PDFS) by 73.9% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 50,102 shares of the technology company’s stock after selling 141,811 shares during the quarter. Russell Investments Group Ltd. owned 0.16% of PDF Solutions worth $600,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    These are some of the media headlines that may have effected Accern Sentiment’s scoring:

    Get PDF Solutions alerts:

    FlipHTML5 Page Flip PDF Turns Social Media Accounts Into Compelling Ones (digitaljournal.com) $23.10 Million in Sales Expected for PDF Solutions, Inc. (PDFS) This Quarter (americanbankingnews.com) PDF Solutions, Inc. (PDFS) Expected to Announce Earnings of $0.06 Per Share (americanbankingnews.com) Basware introduces a ‘Smart PDF’ invoice (itwire.com) ActivePDF Brings Redaction to Businesses, Improving Privacy, Security,… (virtual-strategy.com)

    A number of equities research analysts have recently commented on PDFS shares. Zacks Investment Research cut shares of PDF Solutions from a “hold” rating to a “sell” rating in a report on Wednesday, May 16th. DA Davidson cut their price target on shares of PDF Solutions to $26.00 and set a “buy” rating on the stock in a report on Friday, February 16th. BidaskClub upgraded shares of PDF Solutions from a “strong sell” rating to a “sell” rating in a report on Thursday, May 3rd. Finally, ValuEngine cut shares of PDF Solutions from a “hold” rating to a “sell” rating in a report on Friday, February 2nd. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $22.00.

Top 10 Medical Stocks To Buy Right Now: Houghton Mifflin Harcourt Company(HMHC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Houghton Mifflin Harcourt (NASDAQ:HMHC) was downgraded by analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued on Saturday.

  • [By Max Byerly]

    Shares of Houghton Mifflin Harcourt Co (NASDAQ:HMHC) have earned an average rating of “Hold” from the ten brokerages that are currently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and three have issued a buy recommendation on the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $10.14.

  • [By Rich Smith]

    Shares of Houghton Mifflin Harcourt Company (NASDAQ:HMHC) are rocketing 14.1% as of noon EDT on news that the textbook publisher has agreed to sell its Riverside clinical and standardized testing portfolio to San Francisco-based private equity firm Alpine Investors for $140 million.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Houghton Mifflin Harcourt (HMHC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Shares of Houghton Mifflin Harcourt Co (NASDAQ:HMHC) have been assigned a consensus recommendation of “Hold” from the ten ratings firms that are presently covering the company, Marketbeat.com reports. Three analysts have rated the stock with a sell recommendation, five have given a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $10.14.

Top 10 Medical Stocks To Buy Right Now: Wausau Paper Corp.(WPP)

Advisors’ Opinion:

  • [By Logan Wallace]

    Shares of Wpp Plc (LON:WPP) have been assigned an average recommendation of “Hold” from the nineteen analysts that are covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, nine have given a hold recommendation and nine have assigned a buy recommendation to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is GBX 1,530.46 ($19.94).

  • [By Ethan Ryder]

    WPP (LON:WPP)‘s stock had its “equal weight” rating reaffirmed by stock analysts at Morgan Stanley in a report issued on Thursday.

  • [By Joseph Griffin]

    Shares of Wpp Plc (LON:WPP) have earned an average recommendation of “Hold” from the nineteen brokerages that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and nine have issued a buy rating on the company. The average 12 month price objective among brokers that have covered the stock in the last year is GBX 1,475.29 ($19.64).

  • [By Shane Hupp]

    WPP (NYSE:WPP) was downgraded by analysts at Pivotal Research from a “buy” rating to a “hold” rating in a note issued to investors on Monday, Marketbeat reports.

  • [By Max Byerly]

    WPP (LON:WPP)‘s stock had its “buy” rating reaffirmed by equities researchers at Citigroup in a research note issued on Thursday.

  • [By Joseph Griffin]

    Suntrust Banks Inc. bought a new position in Wpp Plc (NYSE:WPP) during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 7,349 shares of the business services provider’s stock, valued at approximately $583,000.

Top 10 Medical Stocks To Buy Right Now: Navios Maritime Partners LP(NMM)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Navios Maritime Partners (NMM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Buy Right Now: T. Rowe Price Group, Inc.(TROW)

Advisors’ Opinion:

  • [By Shane Hupp]

    Press coverage about T. Rowe Price (NASDAQ:TROW) has trended somewhat positive on Wednesday, according to Accern. Accern rates the sentiment of news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. T. Rowe Price earned a news impact score of 0.20 on Accern’s scale. Accern also assigned media stories about the asset manager an impact score of 47.382716620203 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Max Byerly]

    Shares of T. Rowe Price Group Inc (NASDAQ:TROW) have been assigned a consensus recommendation of “Hold” from the thirteen research firms that are covering the firm, MarketBeat reports. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $118.33.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Thermo Fisher Scientific Inc. (NYSE: TMO) is projected to report quarterly earnings at $2.4 per share on revenue of $5.63 billion.
    Ford Motor Company (NYSE: F) is expected to report quarterly earnings at $0.41 per share on revenue of $37.16 billion.
    Twitter, Inc. (NYSE: TWTR) is projected to report quarterly earnings at $0.11 per share on revenue of $605.26 million.
    Comcast Corporation (NASDAQ: CMCSA) is expected to report quarterly earnings at $0.59 per share on revenue of $22.75 billion.
    General Dynamics Corporation (NYSE: GD) is estimated to report quarterly earnings at $2.52 per share on revenue of $7.6 billion.
    The Boeing Company (NYSE: BA) is expected to report quarterly earnings at $2.58 per share on revenue of $22.24 billion.
    Anthem, Inc. (NYSE: ANTM) is estimated to report quarterly earnings at $4.91 per share on revenue of $22.52 billion.
    Viacom, Inc. (NASDAQ: VIAB) is projected to report quarterly earnings at $0.79 per share on revenue of $3.04 billion.
    Northrop Grumman Corporation (NYSE: NOC) is estimated to report quarterly earnings at $3.61 per share on revenue of $6.61 billion.
    Rockwell Automation Inc. (NYSE: ROK) is expected to report quarterly earnings at $1.81 per share on revenue of $1.66 billion.
    Wipro Limited (NYSE: WIT) is projected to report quarterly earnings at $0.07 per share on revenue of $2.15 billion.
    The Goodyear Tire & Rubber Company (NASDAQ: GT) is expected to report quarterly earnings at $0.46 per share on revenue of $3.82 billion.
    Owens Corning (NYSE: OC) is projected to report quarterly earnings at $0.97 per share on revenue of $1.62 billion.
    T. Rowe Price Group, Inc. (NASDAQ: TROW) is estimated to report quarterly earnings at $1.71 per share on revenue of $1.29 billion.
    Dr Pepper Snapple Group, Inc. (NYSE: DPS) is expected to report quarterly earnings at $1.04 per share on revenue of $1.57 billion.
    Sirius XM Holdings Inc. (NASDAQ: SI
  • [By Shane Hupp]

    Financial Counselors Inc. boosted its holdings in T. Rowe Price Group Inc (NASDAQ:TROW) by 29.7% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,367 shares of the asset manager’s stock after acquiring an additional 772 shares during the quarter. Financial Counselors Inc.’s holdings in T. Rowe Price Group were worth $391,000 as of its most recent filing with the SEC.

Leave a Reply

Your email address will not be published. Required fields are marked *